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Summary 
The crystal structure of the DNA-binding and dimeriza- 
tion domains of the Epstein-Barr virus nuclear antigen 
1 (EBNAI), which binds to and activates DNA replica- 
tion from the latent origin of replication in Epstein- 
Barr virus, was solved at 2.5 A resolution. EBNAI ap- 
pears to bind DNA via two independent regions termed 
the core and the flanking DNA-binding domains. The 
core DNA-binding domain, which comprises both the 
dimerization domain and a helix predicted to bind 
the inner portion of the EBNAI DNA recognition ele- 
ment, was remarkably similar to the structure of the 
papillomavirus E2 protein, despite a complete lack of 
sequence conservation. The flanking DNA-binding do- 
main, only a portion of which is contained in the cur- 
rent structure, consists in part of an a helix whose 
N-terminus contacts the outer regions of the EBNAI 
DNA recognition element. 
Introduction 
Epstein-Barr virus (EBV) is an ubiquitous human y herpes- 
virus that is associated with several malignancies and dis- 
eases, including infectious mononucleosis, Burkitt’s lympho- 
ma, nasopharangeal carcinoma, some types of Hodgkin’s 
disease, and several types of lymphomas in immunocom- 
promised hosts (e.g., AIDS and posttransplant patients) 
(Miller, 1990). In latently infected cells, the EBV genome 
is maintained as an episome, whose persistence requires 
only one virally encoded protein, Epstein-Barr nuclear an- 
tigen 1 (EBNAl) (Yates et al., 1985). EBNAl activates viral 
DNA replication from a c&acting viral DNA sequence, 
oriP, which is composed of two functional subelements 
(FR and DS) separated by 1 kb of DNA (Reisman et al., 
1985). Each subelement contains multiple copies of the 
EBNAI recognition sequence; four copies are present in 
*These authors contributed equally to this work. 
the DS element and 20 in the FR element (Rawlins et 
al., 1985). Through interactions with oriP, EBNAl not only 
plays a role in the initiation of DNA replication, but also 
governs the stable segregation of EBV episomes during 
cell division and can act as an enhancer of transcription 
(Lupton and Levine, 1985; Reisman and Sugden, 1986; 
Krysan et al., 1989; Sugden and Warren, 1989). The mech- 
anism by which EBNAl activates and regulates DNA repli- 
cation from oriP is of interest, not only because of its impor- 
tance in the EBV life cycle, but also because of its 
usefulness as a model system for the initiation of DNA 
replication from cellular origins. Like replication from the 
host cellular origins, replication from oriP is regulated to 
one round per cell cycle and uses the cellular replication 
machinery (Adams, 1987; Yates and Guan, 1991). 
EBNAl encoded by EBV 895-8, the most widely studied 
EBV isolate, comprises 641 amino acids and is a very 
stable dimer both in solution and when bound to its 18 bp 
palindromic recognition sequence (Ambinder et al., 1991; 
Frappier and O ’Donnell, 1991). EBNAI has no sequence 
homology with any origin-binding protein, or any other 
known DNA-binding protein. However,  like other origin- 
binding proteins, EBNAl participates in several higher or- 
der interactions on the origin DNA and distorts the origin 
DNA sequences (Frappier and O ’Donnell, 1991, 1992; 
Hearing et al., 1992; Hsieh et al., 1993). The DNA-binding 
and dimerization domains of EBNAl have been localized 
to within residues 459-607 in the C-terminal portion of the 
protein (Ambinder et al., 1991), and distinct regions of 
EBNAI mediate the higher order interactions of EBNAl 
on oriP (Goldsmith et al., 1993; Frappier et al., 1994; Sum- 
mers et al., submitted). The mechanism by which EBNAI 
interacts with DNA and then subsequently assembles to 
form the higher order complexes on oripawaits high reso- 
lution structural characterization of the EBNAl-origin in- 
teraction. As a first step toward this goal, we have deter- 
mined the crystal structure of the EBNAl DNA-binding 
and dimerization region. Acombination of our biochemical 
and structural studies has revealed that EBNAI is com- 
prised of two distinct DNA-binding domains. The first, or 
core, DNA-binding domain (amino acids 504-604) shows 
a remarkable structural homology with the entire DNA- 
binding and dimerization domain from the E2 protein of 
bovine papillomavirus, which was solved as a complex 
with DNA (Hegde et al., 1992). The second, or flanking, 
DNA-binding domain (amino acids 459-503) although not 
complete in our structure, contains an a helix oriented 
perpendicular to the predicted axis of the modeled DNA 
that is positioned to contact the outer part of the EBNAl 
recognition sequence. 
Results and Discussion 
Structure Solution 
A fragment of EBNAl (residues 470-607; EBNA,,O-,O,) pre- 
viously determined to be active for sequence-specif ic DNA 
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Figure 1. Stereo View Showing a b Sheet Region in the Solvent-Flattened and NC Symmetry-Averaged 3.0 A MIRAS Map 
Superimposed on the map is the model of the protein. Contours drawn at the lo level. 
binding was cloned, overexpressed, and purified from 
Escherichia coli (Barwell et al., 1995; Summers et al., sub- 
mitted). The protein was soluble only in high salt, and or- 
thorhombic, rod-like crystals, with space group P2,2,2,, 
were obtained by lowering the ionic strength. The crystallo- 
graphic asymmetric unit contains one dimer, and thestruc- 
ture was determined by multiple isomorphous replace- 
ment supplemented with anomalous scattering (MIRAS) 
and noncrystallographic symmetry averaging. Single iso- 
morphous replacement with anomalous scattering (SIRAS) 
from a mercury derivative provided most of the phase infor- 
mation to 3.0 A resolution. These phases were subse- 
quently improved by including isomorphous replacement 
phase information from selenium-containing crystals fol- 
lowed by noncrystallographic 2-fold averaging and solvent 
flattening. The final refined 3.0 A electron density map 
was readily interpretable (Figure 1) with some exceptions: 
the first three residues (all derived from the fusion protein) 
of one monomer (monomer a) and the first ten residues 
(four from the fusion and six from EBNAl) of the other 
(monomer b) were not visible. Residues 547-552 of both 
monomers had weak, but interpretable, density. 
Overall Description of Structure 
The core of the EBNA,,mGo, structure contains an eight- 
stranded antiparallel f3 barrel, which is comprised of four 
strands from each monomer, and the f3 strands in each 
monomer are connected by two Q  helices on the outside 
of the barrel (Figure 2). The structure of this domain, which 
comprises residues 504-604 and will be referred to as the 
EBNAl core domain, is very similar to that of the DNA- 
binding domain from the papillomavirus transcription acti- 
vator protein E2 (Hegde et al., 1992). The structures of 
EBNAl and E2 (Protein Data Bank entry 2BOP) are most 
highly conserved in the positions of the f3 barrel and one 
of the two helices (the DNA recognition helix of E2). In 
Figure 2. EBNAl Dimer 
(A) A ribbon diagram of EBNAI viewed along noncrystallographic axis. 
The two monomers are colored in purple and yellow. 
(B) The EBNAI dimer view down the axis of the B barrel. 
Structure of the EBNAI DNA-Binding Domain 
41 
Figure 3. Comparison of the E2 and EBNAl Core Monomers 
(A) The a carbon backbones of EBNAwsmw and E232caas (41 residues 
corresponding to EBNAI residues 505-510; 514-526; 532-538; 561- 
566; 592-600) were overlaid by using the Isq.explicit feature in the 
molecular graphics program O(Jones et al., 1991; rmsdeviation, 0.908 
A). The borders of two loops of EBNAl that are not conserved in E2 
(the proline loop, residues 538-560, and helix 2 of the EBNAI core, 
residues 568-591) are indicated. The DNA recognition helix is marked 
in boldface. 
(B) Sequence alignment of EBNAl and E2. The sequences of EBNAl 
and E2 were aligned on the basis of structural homology. Structurally 
equivalent residues are capitalized. The secondary structure features 
of the molecules are shown above the sequences. Rectangles repre- 
sent helices, and arrows represent f3 strands. The amino acids in E2 
that make sequence-specific contacts with the DNA are shown in bold. 
these regions, the root-mean-square (rms) deviation be- 
tween the two structures is 0.908 A (Figure 3A). This struc- 
tural similarity was not evident from the primary sequence, 
as there is absolutely no sequence conservation between 
the two proteins (Figure 38). Residues 470-503 of EBNAl 
have no counterparts in the E2 DNA-binding domain. 
Within this region of EBNAI, residues 477-490 form an 
a helix that is almost parallel to the noncrystallographic 
axis, is packed against the two helices of the core domain, 
and is connected by an extended loop (residues 490-504) 
to the first strand of the 8 barrel. 
Similarities between the EBNAI Core and the E2 
DNA-Binding Domain 
In both EBNAl and E2, an eight-stranded antiparallel 8 
barrel, comprised of four strands from each monomer, is 
the scaffold of the protein and is responsible for the 
marked stability of the EBNAl dimer. Three features, com- 
mon to E2 and EBNAl, contribute to dimerization: first, a 
hydrogen bond network that connects the carbon back- 
bones of the outer 8 strands of each monomer and forms 
the dimerization interface; second, a set of side chain- 
backbone and side chain-side chain hydrogen bonds that 
connect the two monomers; and third, a core of hydropho- 
bic side chains that projects into the core of the barrel. In 
E2, an important component of the hydrophobic interior 
is tryptophan (W360), which is on the second j3 strand and 
makes van der Waals contacts with its symmetry-related 
mate. W360 is conserved in the E2 protein from all known 
papilloma viruses (Prakash et al., 1992). EBNAl does not 
have such a tryptophan, but tyrosine (Y561) on the third 
8 strand plays an analogous role. The side chain of EBNAl 
Y561 reaches across the core of the barrel and hydrogen 
bonds with Y561 of the other monomer (terminal O-O dis- 
tance, 2.77 A). The phenyl ring of EBNAl Y561 is nearly 
superimposable with the six-membered ring of the E2 
W360 indole side chain. 
In both E2 and EBNAI, there is a bulge in the second 
8 strand that causes the 8 sheet to twist and change direc- 
tion. This bulge, which is conserved despite the lack of 
sequence similarity, results from an alternate hydrogen- 
bonding pattern between the second and third 8 strands. 
Normally, 6 sheets are stabilized by interstrand hydrogen 
bonds between the backbone carbonyl and amide atoms. 
However, the hydroxyl groups of T534 and T357 side 
chains, in the middle of the second 8 strands of EBNAl 
and E2, respectively, make hydrogen bond contacts with 
the backbone amides of EBNAl M563 and E2 L377 in the 
third 8 strand. This causes EBNAl P535 and E2 T358 to 
bulge out of the middle of the second 8 strand. In the E2 
bulge, there is absolute conservation of a threonine or a 
serine in position 359, and the hydroxyl from this residue 
contacts the backbone of the DNA recognition element. 
A similar role is suggested for the EBNAl bulge, which 
contains a serine in position 537. Perhaps the kink in the 
sheet also orients the loop between strands 2 and 3 into 
a position suitable for interaction with the DNA. 
In E2, the residues that make sequence-specific DNA 
contacts are confined to one helix (E2 335-349; recogni- 
tion helix; Hegdeetal., 1992). In the EPdimer, these recog- 
nition helices are positioned to lie in successive major 
grooves on one face of the helix. Five residues of these 
helices, which are confined to one face of the recognition 
helix, make either direct or water-mediated hydrogen 
bonds with three highly conserved bases in the E2 binding 
site located at positions four, five, and six bases away 
from the dyad of the palindromic DNA-binding site (Figure 
4A). The DNA recognition helix in E2 has a structural coun- 
terpart in EBNAl (residues 514-527), and several resi- 
dues in this region of EBNAl, including T515, Y518, N.519, 
R522, K514, and R521, are candidates for residues in- 
volved in sequence-specific DNA binding (Figure 5). The 
functional significance of each of these residues in EBNAl 
has yet to be determined. 
Structural Differences between the EBNAl Core 
Domain and E2 
The differences between E2 and the EBNAI core are con- 
fined to the loops and connections between the 8 strands. 
E2 and EBNAl differ in the connection between the third 
and fourth 8 strands. In E2, this region has both helical 
and 6 sheet character. In EBNAl, the two strands are 
connected by a long helix (14 residues) and a short loop. 
The proteins also differ significantly in the loop between 
8 strands 2 and 3. In E2, this loop contacts the phosphate 
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Figure 4. EBNAl Dimer Modeled on a DNA Molecule Derived from 
the E2 Cocrystal Structure 
(A)The EBNAl dimerwasaligned with the EZdimerasshown in Figure 
3 and then docked onto the 16 bp E2 DNA recognition sequence. The 
recognition helices (513-527) are shown in white. Helix 2 of the EBNAl 
core domain (568-582) is shown in blue. The N-terminal flanking DNA- 
binding domains (477-490) are shown in gold, and p barrel in pink. 
(6) The 16 and 18 bp DNA recognition elements of E2 and EBNAl, 
respectively. The conserved bases in the E2 recognition element that 
are contacted by residues in the recognition helix are boxed, along with 
potentially analogous residues in the EBNAl recognition elements, 
backbone of the DNA near the recognition helix of the 
other monomer (Hegde et al., 1992). In EBNAl, the loop 
between these two strands is positioned similarly but is 
larger by nine residues and contains a proline-rich se- 
quence, PGPGPQPGP, that will be referred to as the pro- 
line loop. The proline loop appears to be mobile, as it is 
in a different conformation in each of the two monomers. 
In monomer a, it extends wing-like from the body of the 
dimer. In monomer b, the proline loop is pushed back 
toward the dimer by crystal contacts with the N-terminus 
of another dimer. For several reasons, we believe that 
this domain is a likely candidate to mediate associations 
between EBNAl and cellular proteins. First, the proline 
loop is highly accessible to solvent and, as such, is posi- 
tioned suitably for contacting other proteins. Second, pro- 
line-rich sequences in other proteins, like signal transduc- 
tion molecules or transcription factors, are known to be 
involved in protein-protein associations. Indeed, the EBNAl 
proline loop has a significant sequence homology to re- 
gions of the hBRM protein (the human homolog of the 
yeast SNF2LSW12 gene product) and the herpes simplex 
ICP4 protein, both of which are known transcriptional acti- 
vators (Roizmann and Sears, 1990; Muchardt and Yaniv, 
1993). EBNAl is also known to be able to activate tran- 
scription when bound to its DNA-binding site. It will be 
interesting to test whether the EBNAl proline loop can 
function as a transcription activation domain. 
The EBNAl DNA-Binding Domains 
The homology of the core of EBNAl with the DNA-binding 
domain of E2 implicates this region of EBNAl in sequence- 
specific DNA binding. Indeed, this assertion is in agree- 
ment with earlier biochemical work from the laboratory of 
D. Hayward that identified approximate N-and C-terminal 
boundaries of a core DNA-binding domain to residues 493 
and 584, respectively (Ambinder et al., 1991). It is also in 
agreement with our observation that a fragment of EBNAl 
containing residues 504-607 binds to the EBNAl DNA- 
binding site specifically, but less avidly than a fragment 
comprising residues 459-607, as tested by electropho- 
retie mobility shift assays and by DNA footprinting (Sum- 
mers et al., unpublished data). The EBNAl and E2 core 
domains differ in their relative contribution to DNA binding. 
The core region in E2 has been shown to be entirely suffi- 
cient for sequence-specif ic DNA binding. In contrast, for 
EBNA, several biochemical observations indicate that se- 
quence-specif ic DNA binding involves residues of EBNAl 
in addition to the core domain. First, EBNAl is known to 
interact with a longer stretch of bases compared with E2 
(Figure 4B), and the dimensions of the EBNAl core do- 
main are inconsistent with an interaction with the longer 
binding site. E2 binds a 16 bp palindrome, and the E2 
DNA recognition helix recognizes bases between the third 
and the sixth positions away from the dyad axis of the 
palindrome. The consensus EBNAl binding site com- 
prises an 18 bp palindrome, and residues from the third 
to the eighth away from the dyad of the palindrome play 
an important role in governing sequence specificity (Am- 
binder et al., 1990; Frappier and O ’Donnell, 1992). Sec- 
ond, EBNAl sequences between amino acids 459 and 504 
have been clearly shown to be involved in DNA binding. 
EBNAl fragments that include this region as well as the 
core domain have higher affinities for the EBNAl consen- 
sus site than the core domain (Ambinder et al., 1991). 
These additional residues appear to play a role in base 
discrimination, since mutations made between amino acid 
459 and amino acid 485 have been shown to have pro- 
found effects on the sequence-specif ic DNA binding prop- 
erties of EBNAl (Ambinder et al., 1991; Chen et al., 1993). 
Indeed, a direct role for EBNAl amino acids 458-478 in 
DNA binding was demonstrated when a peptide corre- 
sponding to this region was shown to bind DNA (nonspecif- 
ically) when dimerized (Chen et al., 1994). 
These biochemical experiments that point to an involve- 
ment of residues N-terminal to the core domain in DNA 
binding and the structural and biochemical studies that 
implicate the core region in DNA binding can be reconciled 
by positing that EBNAl contains two distinct domains that 
contribute to sequence-specif ic DNA binding: a core do- 
main, which likely interacts with DNA as does the homolo- 
gous DNA-binding domain of E2, and a flanking domain, 
whose interaction with DNA is not yet understood. To shed 
some light on the structural relationship of the core and 
flanking domains with the DNA, we modeled the EBNAl 
dimer on DNA, using the E2 DNA structure as a guide. 
First, EBNAl and E2 were aligned by using both the homol- 
ogous 8 strands and the recognition helix, and then 
EBNAl was oriented on the E2 DNA fragment (Protein 
Structure of the EBNAl DNA-Binding Domain 
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Figure 5. Side Chains in EBNAI That Are in Position to Make Se- 
quence-specific Contacts with DNA, Viewed from the Perspective of 
the DNA. 
Shown are the side chains in the EBNAl recognition helix (in white) 
and the side chains in the putative flanking DNA-binding domain (in 
yellow) that are positioned to make contacts with the EBNAl DNA 
recognitionelement. Prepared with INSIGHTII(Biosym, Incorporated). 
Data Bank entry ZBOP) (Figure 4). Not surprisingly, the 
EBNAl core DNA-binding domain fits the E2 DNA element 
snugly and, like E2, the core domain is oriented to contact 
the inner portion of the EBNAl binding site. Our model 
also clearly shows that a portion of the flanking domain 
is oriented suitably to contact the outer two or three bases 
of the EBNAI DNA-binding site, with the N-terminus of 
the helix from 477-490 in very close proximity to the bases. 
This helix contains several basic residues well positioned 
to hydrogen bond with the bases (Figure 5). 
Model for Cooperative Binding to Two Sites 
Positioned as in Origin DNA 
The origin of latent EBV DNA replication (the DS element 
of oriP) contains four 18 bp binding sites for EBNAl dimers 
(sites 1, 2, 3, and 4; Rawlins et al., 1985). The sites are 
functionally arranged in sets of two (sites 1 and 2 and sites 
3 and 4), and replication activity requires the integrity of 
either of the two sets of sites (Harrison et al., 1994). The 
binding of EBNAl to each set of sites is cooperative. For 
instance, sites 1 and 2 are bound at the same concentra- 
tion of EBNAl even though the affinity of EBNAl for site 
1 is IO-fold higher than for site 2 (Frappier and O ’Donnell, 
1992; Harrison et al., 1994; Summers et al., submitted). 
We were therefore interested in modeling the structure of 
EBNAl bound to a DNA segment containing two 18 bp 
binding sites that are separated by 3 bp, the same spacing 
that occurs in the EBV origin. 
The purpose of modeling the structure of EBNAl bound 
to two adjacent sites was to explore the EBNAl-EBNAl 
interface that might mediate cooperative binding to DNA, 
and an interaction that might contribute to interdimerasso- 
ciation was revealed. The DNA-binding outer helix (resi- 
dues 477-490) in each dimer is in position to interact with 
the C-terminal helix (residues 568-584) of the core domain 
from the adjacent dimer (Figure 6). This interaction, to- 
gether with the symmetry-related equivalent, would result 
in the formation of a four-helix bundle that might stabilize 
Figure 6. Model of EBNAI Dimers Bound to Two Sites That Mimic 
the Position of the EBNAl Sites in the EBV Origin 
To align the two sites, the following procedure was adopted. First, 
the overhanging base of the 16 bp E2 oligonucleotide, which did not 
conform with normal helix parameters, was deleted. Five bases of B 
form DNA were then added to one end of the blunt 16-mer by use of 
the program INSIGHT II (Biosym, Incorporated), and one base pair 
was added to the other end. Two of the resulting 22.mers were then 
connected by superimposing the 5 bp extensions from each fragment. 
The final DNA molecule contained two 18 bp regions separated by 
three bases of B-form DNA. EBNAl was then docked onto each of 
the two sites as was done for the representation in Figure 4. We did 
not attempt to alter the sequence of the E2 DNA fragment to match 
the EBNAl consensus. Ribbon diagrams show two EBNAl dimers 
modeled onto two E2 DNA recognition sites separated by 3 bp of 
straight B-form DNA. The color scheme is as described in Figure 4. 
Two potential regions of dimer-dimer contact are apparent. The N-ter- 
mini of internal monomers are in close proximity underneath the DNA 
helix. The N-terminal ends of the two internal flanking DNA-binding 
domains (477-490) and two helices of the EBNAl core domain (568- 
582) form a helix bundle between the two dimers. 
the dimer-dimer interaction on DNA. Though the idea is 
speculative, it is difficult to envision a packing of two 
EBNAl dimers on sites only three base pairs apart that 
excludessuch an interaction. Furthermore, this interaction 
is consistent with the observation that, when EBNAl is 
bound to the four sites within the DS element, the three 
base pairs between the two EBNAl binding sites are pro- 
tected against digestion with either DNasel or chemical 
footprinting agents (Summers et al., submitted). In keep- 
ing with this model, a four-helix bundle has been shown 
to mediate the interaction of lac repressor dimers (Fried- 
man et al., 1995). 
Finally, the interactions depicted in this model cannot 
entirely explain the mechanism of cooperative interaction. 
Deletion analysis of EBNA1459-607 indicated that the coop- 
erative binding of EBNAl diminished gradually as increas- 
ingly larger deletions from amino acid 459 to amino acid 
470 were constructed (Summers et al., submitted). It is 
not yet clear whether residues 459-470 comprise part of 
the actual interface between the two dimers or, alterna- 
tively, stabilize the interdimer associations that are shown 
in our model. 
Implications for Viral DNA Replication 
The structural homology between the DNA-binding do- 
mains of EBNAl and E2 allowed us to suggest a mecha- 
nism for EBNAl DNA binding and to identify regions of 
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potential functional importance that were not revealed ei- 
ther by standard algorithms for protein homology searches 
or by mutagenesis experiments. The structural homology 
also prompted us to compare more closely the properties 
of the two intact proteins and, in this new light, consider- 
able similarity was revealed. First, the two proteins share 
many biochemical traits, including dimerization, coopera- 
tive binding to multiple sites in theviral genome, homotypic 
interaction at a distance when bound to DNA (with con- 
comitant DNA looping) and ability to activate transcription 
by RNA polymerase II (Reisman and Sugden, 1986; Giri 
and Yaniv, 1988; Sugden and Warren, 1989; Frappier and 
O ’Donnell, 1991; Knightetal., 1991; Suet al., 1991; Steger 
et al., 1995). Second, EBNAl and E2 have functional com- 
monalities; both proteins bind to sequences within origin 
DNA and play a role in the initiation of viral DNA replication. 
These similarities must now be incorporated into our cur- 
rent understanding of the mechanisms of EBV and papil- 
loma DNA replication. In EBV, EBNAl is the only protein 
required for replication. EBNAl has no intrinsic enzymatic 
activity and thus is thought to activate replication by adopt- 
ing a specific nucleoprotein structure on the origin that 
serves to nucleate the assembly of the host cell replication 
machinery by protein-protein associations. In contrast, 
the papillomaorigin contains binding sites for two proteins, 
El and E2 (Ustav et al., 1991). Both proteins are required 
for replication in vivo, but only El, which is an ATP- 
dependent DNA helicase (Seo et al., 1993; Yang et al., 
1993), is absolutely required for replication in vitro (Ustav 
and Stenlund, 1991; Yang et al., 1991; Bonne-Andrea et 
al., 1995). E2 appears to play a role in the assembly or 
stabilization of El on the origin (Mohr et al., 1990; Seo 
et al., 1993). What might be the functional connections 
between EBV and papilloma replication? Perhaps the two 
DNA-binding domains of EBNAl have separate roles, akin 
to those performed separately by El and E2. The major 
role of the EBNAl core DNA-binding domain, analogous 
to that performed by E2, might be in tethering the flanking 
domain of EBNAl to the origin. The flanking domain may 
be a functional homolog of the El DNA-binding domain 
and, though this domain has no obvious sequence similar- 
ity to El, it will be interesting to discover whether there 
is structural homology. The structural similarity between 
EBNAl and E2 may also point to a common evolutionary 
ancestor and raises the possibility that there is a family 
of mammalian DNA-binding proteins, and perhaps specifi- 
cally origin-binding proteins, with similar dimeric e barrel 
motifs. 
Finally, the structure of EBNAl also has implications for 
EBV antiviral therapy. Latent infection with EBV is associ- 
atedwithanumberof malignanciesand isaseriousclinical 
problem for immunocomprimised patients where it causes 
several types of B-cell lymphomas. In latent EBV infection, 
several different viral polypeptides can be expressed, but 
EBNAl is the only viral protein to be expressed in all types 
of latent infection (reviewed by Klein, 1989). EBNAl is 
thus the most promising target for EBV antivirals. Since 
EBNAl has no known enzymatic activity, inhibitors of 
EBNAl function must target other aspects of EBNAl func- 
tion, like DNA binding. The structure of EBNAl reported 
here indicates that each DNA-binding domain is localized 
to a small region of the molecule and the interaction be- 
tween EBNAl and DNA may well be able to be inhibited 
by small molecules. A high resolution structure of the co- 
crystal of EBNAl and its cognate DNA element will reveal 
the details of the association. 
Experimental Procedures 
EBNA1470-S07 was cloned into the T7 polymerase expression vector 
petl5b (Novagen, Madison, WI), and overexpressed in the bacterial 
strain BL21(DE3) pLysS as a fusion to an N-terminal six-histidine tag 
(Studier et al., 1990). The protein was purified by a combination of 
heat treatment, heparin affinity chromatography, nickel chelate affinity 
chromatography, and finally, after removal of the histidine tag bydiges- 
tion with thrombin, cation exchange chromatography (Barwell et al., 
1995). Four amino acids, GSHM, persist from the fusion protein and 
extend from the N-terminus of EBNAl. The protein was concentrated 
using a Centricon ultrafiltration membrane and stored frozen at 7-8 
mglml in a solution containing 1 mM HEPES (pH 7.2), 500 mM NaCI, 
and 10 mM DTT. Crystalsof EBNAl r70.60,weregrown byvapordiffusion 
in hanging drops. The drops were formed by mixing an equal volume 
of the protein solution with a reservoir solution that contained 50 mM 
MES (pH 6.5), O-150 mM NaCI, and 10 mM DTT. Crystals, with space 
group P2,2,2,, formed within hours and typically grew to 0.2 x 0.2 x 
0.8 mm in a few days. Data were collected from crystals maintained 
at room temperature or at -175°C on an R axis area detector with a 
rotatinganodex-raysourceandcu K, radiation. The crystalsdiffracted 
to beyond 2 A and contained one dimer per asymmetric unit. For low 
temperature data collection, which was essential for the pCMB data, 
the crystals were slowly transferred to a cryoprotectant (20% glycerol 
in reservoir solution), mounted in a loop made from a fiber of dental 
floss, and frozen in a stream of NP gas. The diffraction data were 
integrated with DENZO and the intensities scaled with SCALEPACK 
(Z. Otwinowski). Two heavy atom derivatives, pCMB and selenium, 
were used in the structure determination. A pCMB derivative was ob- 
tained by soaking crystals for 1 week in a 1 mM solution of pCMB in 1 
mM MES (pH 6). Selenium was incorporated into EBNAl byexpressing 
and purifying EBNAl from 8834 (Novagen),a met auxotrophic strain 
of E. coli, grown in the presence of selenomethionine. Using data from 
frozen native and derivative crystals, five heavy atom sites in a pCMB 
derivative were determined from isomorphous difference Patterson, 
anomalous difference Patterson, and difference Fourier maps. Four 
of these sites were pairwise consistent with a noncrystallographic 
P-fold axis roughly parallel with the a axis and displaced by -20 A in 
the b direction. SIRAS phase calculations with the pCMB derivative 
followed by solvent flattening produced an electron density map that 
confirmed the position and direction of the local dyad axis. Additional 
phase information was then obtained by including a selenomethionine- 
containing protein as an isomorphous derivative. A cross-difference 
Fourier based on the solvent-flattened SIRAS phases revealed eight 
tentative selenium sites, and the six that were pairwise consistent with 
the local dyad axis were incorporated into the phasing. After maximum 
likelihood refinement of heavy atom, scaling, and lack of closure pa- 
rameters, the mean figure of merit was 0.589 for the resulting MlRA$ 
phase set. Although the phasing power (which falls below 1 .O at 4 A 
resolution) and statistics are poor for the selenium data set, the maps 
nevertheless improved somewhat. The noncrystallographic symmetry 
operator was then refined by least squares against a solvent-flattened 
map produced from-the MIRAS phases by using all density within a 
sphere of radius 18 A centered on the dimer. For the refined operator, 
within this sphere, the resulting correlation coefficient between the 
local dyad related density was 0.701. An envelope mask appropriate 
for averaging over the dimer was then interactively constructed while 
viewing a “skewed” version of the map so as to look down the local 
dyad axis. A final solvent-flattened, NC symmetry-averaged MIRAS 
map at 3 A resolution was then obtained by 16 averaging, flattening, 
and phase combination cycles. All heavy atom refinement, phasing, 
solvent flattening, operator refinement, averaging, and map calcula- 
tions were carried out with the PHASES program package (Furey and 
Swaminathan, 1995). The electron density map was extremely clear. 
A model was built by use of the program 0 (Jones et al., 1991) and 
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then refined againstthe25Aroom temperaturedata set byacombina- 
tion of simulated annealing (program XPLOR 119871; A. T. Briinger, 
Howard Hughes Medical Institute and Department of Molecular Bio- 
physics and Biochemistry, Yale University, New Haven, CT) and re- 
strained least squares (GPRLSA [an optimized local version of 
PROLSQ, Hendrickson and Konnert, 19801; Furey et al., 1982). After 
making minor adjustments determined from a series of omit maps and 
incorporation of strongly bound water molecules, the refined model 
contained 271 amino acids (residues 470-607 in one monomer and 
475-607 in the other) plus 72 water molecules. Structural differences 
in the two monomers at the N-terminus and in an external loop likely 
result from different packing interactions caused by the “local” nature 
of the dimer 2-fold symmetry. The refined model has rms deviation 
from ideality of 0.017 A and 3.9 degrees for bond distances and angles, 
respectively. The final R factor is 0.179 for all 9727 reflections between 
8 and 2.5 A , and Ramachandran plots show no violations for either 
monomer with over 93% of all residues in most favored regions. See 
Table 1 for experimental data. 
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